Save up to 90% on a Hartford Courant subscription. Click here to sign up now!
CT Now

FDA protest

SPEAKING OUT: Nearly 200 people protested at FDA headquarters in Maryland in September in one of several rallies against the agency’s decision to delay approval of Dendreon’s Provenge, a prostate-cancer vaccine. The activists also called for greater access to experimental cancer medications. Their rallies followed controversy over the FDA’s flip-flop on Provenge.Leslie Mulkey